Welcome to Coronado Research
Coronado Research is a consultancy-led, professional services organisation, which provides support to pharmaceutical, biotechnology, and medical device companies. Our objective is to optimise the clinical development process by leveraging all the data available using AI, ML, and leading technologies.
Our practices cover Regulatory Strategy, Advanced Analytics, Market Access and Health Economics, and Technology. Our teams work with customers to “join-the-dots” between these disciplines to ensure treatments are developed with the end in mind and better match market needs.
Dr Nicholas Edwards Chair
Nick Edwards has extensive experience in the pharmaceutical industry, having spent 18 years with Andersen Consulting (now Accenture), where he led the firm’s global Pharmaceutical R&D business. During his tenure, he worked on projects with major pharmaceutical companies, such as building a global drug development function, developing drug research strategies, and supporting organisational integration after mergers. In 2005, Nick co-founded Kinapse, a consulting and outsourcing business focused on the pharmaceutical industry, which he chaired until its sale in 2016. He has also consulted for the UK Department of Health and supported life science start-ups. Currently, Nick also chairs Prescient Healthcare Group and Oxford Medical Products, both of which focus on biopharmaceutical and medical innovation.
Andrew MacGarvey Chief Executive Officer
Andrew MacGarvey has been involved in clinical development for over 25 years. In his early career he worked for a variety of Contract Research Organisations in Statistical Programming and Clinical Data Management. Andrew’s interest in technology took him to a software company in the early days of Electronic Data Capture but for the last 16 years he has focussed on data analytics.
With a reputation for building strong, values-driven teams, he has grown businesses and taken them to new geographies including EMEA, the US, and Asia.
In Coronado, Andrew brings all his experience together to deliver a vision of optimised clinical trials and a disruptive approach to drug development.
Find out more
While we complete the new website for Coronado Research you can contact us using the email address below or follow us on LinkedIn. We will post latest news to the Coronado Research LinkedIn page.
email us at: datadriven@coronado-research.com